Ming Yin insider trades: China Biologic Products (CBPO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ming reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 15, 2016 | CBPO | ↓ Sell | 20,334 | $124.32 | $2.5M | Direct | Aug 17, 2016 (2d) |
| May 20, 2016 | CBPO | ↓ Sell | 19,618 | $113.64 | $2.2M | Direct | May 23, 2016 (3d) |
| Sep 15, 2015 | CBPO | ↓ Sell | 20,508 | $95.55 | $2.0M | Direct | Sep 16, 2015 (1d) |
| Sep 12, 2014 | CBPO | ↓ Sell | 3,073 | $54.00 | $166K | Direct | Sep 16, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ming Yin's insider trades
Ming Yin is Sr. Corporate Vice President at China Biologic Products (CBPO). Since Sep 12, 2014, Ming has reported no open-market purchases and 4 sales worth $6.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBPO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.